Work for a Member organization and need a Member Portal account? Register here with your official email address.

Article

DeepCure scores $40M for AI-enabled drug discovery

poba/Getty Images

Nov. 9, 2021

By Emily Olsen

DeepCure, developer of small molecule therapeutics using an AI-enabled drug discovery platform, raised $40 million in Series A funding.

The round was led by Morningside Ventures with participation from existing investors TLV Partners, Sapir Venture Partners and Benon Group Ltd.

DeepCure said the Series A brings its total raise to $47 million.

Read on MobiHealthNews

Exploration of Methods for Many-Site Genome Editing with MAGE

Sterling, B. "Exploration of Methods for Many-Site Genome Editing with MAGE"

Professor Jacobson was recognized for his work developing electronic ink.

The screen technology used in e-readers like the Amazon Kindle was conceived by undergraduates at MIT.